Protective effect of the 5-lipoxygenase inhibitor ardisiaquinone A on hepatic ischemia-reperfusion injury in rats.

The protective effects of the 5-lipoxygenase inhibitor ardisiaquinone A, a compound isolated from Ardisia sieboldii, on hepatic ischemia-reperfusion (I/R) injury was studied in rats. Hepatic I/R injury was induced by occlusion of the portal vein and the hepatic artery for 60 min, followed by reperfusion for 24 h. The content of leukotriene B (4) (LTB (4)) in the liver increased during ischemia. Serum alanine aminotransferase (ALT) levels, a marker of hepatic parenchymal cell injury, and hepatic myeloperoxidase (MPO) activity, a marker of neutrophil accumulation, significantly increased 6 - 9 h after reperfusion. Treatment with ardisiaquinone A (0.1 - 2 mg/kg, i. p.) 30 min prior to ischemia dose-dependently prevented the increase in LTB (4) content during ischemia (ID (50) = 0.645 mg/kg) with a slightly higher potency than that of AA-861 (ID (50) = 0.728 mg/kg), a known reference 5-lipoxygenase inhibitor. Ardisiaquinone A also attenuated the increase in MPO activity and serum ALT levels at 6 h after reperfusion (ID (50) = 1.71 mg/kg and 4.28 mg/kg, respectively). These protective effects were more efficient than those of AA-861 (ID (50) = 1.86 mg/kg and no effect, respectively), LY255283 (ID (50) = 18.1 mg/kg and 11.5 mg/kg, respectively), and ONO-4057 (ID (50) = 8.38 mg/kg and 9.44 mg/kg, respectively), which are LTB (4) receptor antagonists. These results suggest that ardisiaquinone A may protect the liver against damage due to I/R in rats.
AuthorsNobuaki Matsui, Nobuyuki Fukuishi, Yoshiyasu Fukuyama, Yumiko Yasui, Masaaki Akagi
JournalPlanta medica (Planta Med) Vol. 71 Issue 8 Pg. 717-20 (Aug 2005) ISSN: 0032-0943 [Print] Germany
PMID16142634 (Publication Type: Journal Article)
Chemical References
  • Benzoquinones
  • Enzyme Inhibitors
  • Lipoxygenase Inhibitors
  • Plant Extracts
  • Protective Agents
  • ardisiaquinone A
  • Animals
  • Ardisia
  • Benzoquinones (administration & dosage, pharmacology, therapeutic use)
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors (administration & dosage, pharmacology, therapeutic use)
  • Lipoxygenase Inhibitors
  • Liver Diseases (enzymology, prevention & control)
  • Male
  • Phytotherapy
  • Plant Extracts (administration & dosage, pharmacology, therapeutic use)
  • Protective Agents (administration & dosage, pharmacology, therapeutic use)
  • Rats
  • Rats, Wistar
  • Reperfusion Injury (prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: